Assessing radiological response of IDH-mutated glioma to vorasidenib by tumor diameter slopes: a series of 8 cases.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 42233993.
- Also identified by DOI 10.1007/s00701-026-06944-x.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The INDIGO trial demonstrated improved progression-free survival under vorasidenib in IDH-mutated grade 2 glioma patients. However, the pattern of vorasidenib effects remains unknown. We thus performed a retrospective analysis of tumor kinetics in eight patients enrolled in the INDIGO trial. Tumor diameters (computed from FLAIR volumetry) and their slopes were individually estimated, before and under vorasidenib. Three patients showed no change in slope. Three patients exhibited a marked slope decrease, and two demonstrated slope inversion. Tumor diameter slopes allows individual assessment of radiological response, providing clinically relevant insights that cannot be captured by the cohort-level analysis performed in the INDIGO trial.